Dr Hui Xiao,regeneron,United States

Dr. Hui Xiao 🧪🔬 is a distinguished scientist specializing in biochemistry, structural biology, and mass spectrometry. With a strong focus on microtubule dynamics, protein interactions, and drug mechanisms, he has made significant contributions to understanding cellular processes. As a co-first author and lead researcher, his work has been published in esteemed journals like J. Mol. Biol., Biochemistry, and J. Biol. Chem.. His expertise spans hydrogen-deuterium exchange, proteomics, and molecular stabilization studies. Dr. Xiao’s research has advanced drug discovery, particularly in cancer therapeutics and protein biochemistry. 📚🔍 His innovative approaches continue to impact biomedical sciences globally. 🌍✨

Publication Profile

Education

Dr. Hui Xiao 🎓 holds a Ph.D. in Analytical Chemistry from the University of Massachusetts, Amherst (2005) and a degree in Applied Chemistry from Peking University, China (1992). Currently serving as an Associate Director at Regeneron Pharmaceuticals 🏢, he specializes in protein characterization using mass spectrometry. With over a decade at Regeneron, he has progressed through roles as a Senior Staff Scientist and Staff Scientist. Previously, he held academic positions at Albert Einstein College of Medicine 🧬, advancing from Instructor to Research Associate Professor. His expertise spans analytical chemistry, protein analysis, and therapeutic protein research, making significant contributions to biomedical science. 🔬

Professional Impact

Dr. Hui Xiao 🎓 is a distinguished scientist with over 20 years of experience in academia and the biotechnology industry. Currently, he serves as an Associate Director of Analytical Chemistry at Regeneron Pharmaceuticals 🏢, a leading biotech company. His expertise lies in mass spectrometry applications for protein characterization 🔬, contributing to advancements in therapeutic development. Before joining Regeneron, Dr. Xiao held esteemed faculty positions at Albert Einstein College of Medicine 🧬, progressing from Instructor to Research Associate Professor. His extensive research and leadership have played a crucial role in bridging analytical chemistry with biopharmaceutical innovation, impacting drug discovery and development. 🚀

Scientific Contributions

Dr. Hui Xiao 🎓 is a leading expert in protein-ligand interactions, structural proteomics, and therapeutic protein analysis 🔬. His pioneering work includes the application of hydrogen-deuterium exchange mass spectrometry (HDX-MS) for epitope mapping 🧩 and microtubule stabilization research. With a deep focus on drug characterization and regulatory sciences, his contributions have significantly advanced biopharmaceutical development 💊. His expertise in mass spectrometry-driven protein analysis has helped enhance the understanding of molecular mechanisms, improving therapeutic strategies. Through innovation and research, Dr. Xiao continues to play a vital role in shaping the future of biopharmaceutical science and drug discovery. 🚀

Potential Considerations

Dr. Hui Xiao 🎓 is a renowned expert in analytical and protein chemistry, with groundbreaking work in epitope mapping and protein characterization 🔬. While his contributions significantly impact drug development, the Pharmaceutical Innovation Achievement Award 🏆 may prioritize direct advancements in drug discovery and novel pharmaceutical interventions 💊. His research has important regulatory and therapeutic implications, but highlighting specific drug innovations or regulatory breakthroughs he has led would further strengthen his case. By showcasing his role in pioneering pharmaceutical advancements, Dr. Xiao’s influence in shaping modern biopharmaceutical science can be fully recognized and appreciated. 🚀

Research Focus

Dr. Hui Xiao’s research primarily focuses on analytical chemistry 🧪, particularly in the quantitative analysis of biomolecules 🧬 using advanced mass spectrometry techniques ⚖️. His work involves CRISPR sgRNA modification analysis 🧬🔬 and the development of LC-MS-based assays for biological therapeutics 💊. He specializes in phosphorothioate isomer detection 🔄 and liquid chromatography-multiple reaction monitoring-mass spectrometry (LC-MRM-MS) 📊 for precise biomolecular quantification. His contributions are crucial in drug discovery 🏥, gene editing 🧬, and biopharmaceutical development 💉. His expertise bridges biotechnology 🔬 and analytical methodologies 📈, advancing innovations in therapeutic monitoring and molecular diagnostics 🏥.

Publication Top Notes

Quantitative Analysis of Phosphorothioate Isomers in CRISPR sgRNA at Single-Residue Resolution Using Endonuclease Digestion Coupled with Liquid Chromatography Cyclic Ion Mobility Mass Spectrometry (LC/cIMS)

Generic Enrichment Method for Liquid Chromatography-Multiple Reaction Monitoring-Mass Spectrometry Assay for Quantitative Measurement of Biological Therapeutics in Serum

Tang Jin-Bao | Pharmacology | Best Researcher Award

Published on 18/02/202518/02/2025 by Top Pharmaceutical

Tang Jin-Bao | Pharmacology | Best Researcher Award

Prof. Dr Tang Jin-Bao,Shandong Second Medical University,China

Prof. Dr. Jin-Bao Tang, a licensed pharmacist in China, is a professor at Shandong Second Medical University. He earned his Ph.D. in Microbial and Biochemical Pharmacy from Shandong University in 2023. An esteemed graduate sponsor in Shandong Province, he specializes in Biotechnological Pharmaceutics and Pharmaceutical Engineering. His research focuses on developing novel immunoassay biosensors for proteins and peptides. With multiple high-impact publications in Food Chemistry and Analytical Bioanalytical Chemistry, he has pioneered advanced immunosensor technologies. His innovative contributions to biosensor development enhance precision in food safety and biomedical analysis. 🔬📚

Publication Profile

Scopus

Education

Prof. Dr. Jin-Bao Tang 🎓 holds a Doctorate in Microbial and Biochemical Pharmacy from Shandong University (2023) and is a licensed pharmacist in China. As a distinguished professor at Shandong Second Medical University, he plays a vital role in educating future pharmaceutical professionals in Biotechnological Pharmaceutics and Pharmaceutics Engineering 🧪. His dedication to academia is evident through his mentorship and contributions to pharmaceutical sciences. Recognized as an excellent graduate sponsor of Shandong Province 🏆, Dr. Tang’s expertise and commitment continue to shape the next generation of researchers and industry leaders in the field of pharmacy. 💊

Scientific Community

Prof. Dr. Jin-Bao Tang 🧑‍🔬 has made a significant impact in the scientific community through his groundbreaking research in biotechnology and pharmacology. His publications appear in prestigious journals such as Food Chemistry, International Journal of Biological Macromolecules, Food Control, and Analytical Bioanalytical Chemistry 📚. His collaborative work has led to advancements in oriented antibody immobilization, photoconjugation strategies, and biosensor technology 🧪, with profound implications for public health, biotechnology, and pharmacological applications. Through his innovative contributions, Prof. Tang continues to shape the future of pharmaceutical sciences, enhancing diagnostic and therapeutic approaches for global healthcare. 🌍💊

Research Contributions

Prof. Dr. Tang Jin-Bao’s research revolves around developing novel immunoassay biosensors for protein and peptide detection 🧪🔬. His pioneering work has significantly advanced biosensing technology, particularly in food safety and biomedical analysis 🍎⚕️. Over the past five years, his high-impact publications have introduced innovative techniques such as electrochemical immunosensors for aflatoxin detection ⚡, bioluminescent immunoassays using antibody-nanoluciferase conjugates ✨, and Fc-specific antibody modifications for enhanced biosensor performance 🧫. Additionally, his photoconjugation strategies have led to stable fluorescent antibody fabrication 🌟. These breakthroughs contribute immensely to food safety, pharmaceutical analysis, and immunodiagnostics, demonstrating the real-world impact of his research. 🚀

Research Focus

Prof. Dr. Jin-Bao Tang’s research primarily focuses on biosensors 🧪, immunoassays 🏥, and antibody engineering 🧬 for food safety and biomedical applications. His work involves developing electrochemical immunosensors ⚡, bioluminescent assays 💡, and advanced antibody modifications 🏗️ to enhance the detection of harmful contaminants like aflatoxin B1 🍄⚠️. He explores oriented antibody immobilization 🎯 to improve sensitivity and specificity in bioanalytical methods. Additionally, his research extends to drug delivery systems 💊, particularly in pulsatile release formulations ⏳, using innovative polymers. His contributions advance food safety 🥗, biomedical diagnostics 🏥, and pharmaceutical technologies 💊 for global health and safety.

Publication Top Notes

A facile and effective electrochemical immunosensor based on controlled and oriented immobilization of natural antibodies for sensitive detection of aflatoxin B₁

Development of a bioluminescent immunoassay based on Fc-specific conjugated antibody–nanoluciferase immunoreagents for determining aflatoxin B₁

Fabrication of cysteine-modified antibodies with Fc-specific conjugation for covalent and oriented immobilization of native antibodies

Preparation of enteric capsules with pulsatile drug delivery potential using pullulan and polyacrylic acid resin III

Muhammad Ayub | Drug Discovery and Development | Best Researcher Award

Published on 14/02/202514/02/2025 by Top Pharmaceutical

Muhammad Ayub | Drug Discovery and Development | Best Researcher Award

Dr Muhammad Ayub,University of Sahiwal,Pakistan

Dr. Muhammad Ayub 🎓🔬 is an accomplished analytical chemist specializing in the extraction, purification, and characterization of bioactive compounds from plant materials. He earned his Ph.D. in Analytical Chemistry from the University of Agriculture Faisalabad, Pakistan (2018). With expertise in advanced chromatographic techniques (HPLC, GC-MS, NMR) and biological assays, he has contributed significantly to sustainable extraction methodologies. As a Principal Investigator at the University of Sahiwal, he led research on cost-effective extraction of volatile bioactives. His international experience includes research at The University of Queensland, Australia. Passionate about innovation, he mentors students in analytical chemistry and bioactive research. 🌿

Education

Dr. Muhammad Ayub 🎓 is a distinguished analytical chemist from Pakistan with an impressive academic background. He earned his Ph.D. in Analytical Chemistry in 2018 from the University of Agriculture Faisalabad 🏛️. Prior to this, he completed his M.Phil. in Analytical Chemistry in 2011 from Government College University Faisalabad 📚. His journey in chemistry began with an M.Sc. in Analytical Chemistry in 2009 from the University of Agriculture Faisalabad, following a B.Sc. in Chemistry, Zoology, and Geography from Government College University Faisalabad in 2007 🔬. His expertise contributes significantly to research and advancements in analytical sciences. 🔍✨

Research Statement

Dr. Muhammad Ayub is an expert in the extraction, isolation, and characterization of bioactive compounds from plant materials 🌿. He utilizes advanced techniques such as hydro distillation, steam distillation, microwave-assisted extraction, superheated steam extraction, and supercritical fluid extraction ⚗️. His research focuses on optimizing essential oil extraction to enhance yield and quality while exploring the role of micronutrients in plant growth 🌱. With expertise in chromatographic methods and characterization tools like GC-MS, LC-MS, and NMR 🔬, he evaluates antibacterial, antifungal, antioxidant, and antitumor activities 🦠. His pioneering work in superheated steam extraction has revolutionized sustainable and efficient methodologies. 🚀

Research Experience

Dr. Muhammad Ayub is a dedicated researcher specializing in the extraction and characterization of bioactive compounds. As a Principal Investigator at the University of Sahiwal (2022–2024) 🏛️, he led an HEC-NRPU project focusing on cost-effective methods for extracting volatile bioactives from oleo-gum resins 🌿. His expertise spans superheated steam extraction, bioactive purification, and antimicrobial assessments 🧪. With postgraduate research experience in Pakistan and Australia 🇦🇺, he has worked extensively on chromatographic techniques, essential oil purification, and antioxidant studies. His mentorship has guided numerous students in advanced extraction techniques, making significant contributions to natural product chemistry 🔬.

Teaching Experience

Dr. Muhammad Ayub is a dedicated lecturer in chemistry at the University of Sahiwal, where he has been serving permanently since March 2020 🏫. He supervises research students and teaches analytical chemistry at both undergraduate and postgraduate levels 🧪. Previously, he worked as an Assistant Professor at the University of Okara (Feb 2019 – Feb 2020) on a one-year contract, instructing analytical and inorganic chemistry 📚. Before that, he was a Guest Assistant Professor at the same university (Oct 2018 – Feb 2019), specializing in analytical chemistry at the undergraduate level. His expertise and passion for teaching continue to inspire students 🎓.

Academic Service

Dr. Muhammad Ayub has held several key academic and administrative positions in Pakistan. He served as the Coordinator for the BS Chemistry Program at the University of Okara from February 2019 to February 2020 🧪. Currently, he is the In-Charge of Chemical Laboratories at the University of Sahiwal, a role he has held since January 2021 🏛️. Additionally, he worked as the Deputy Director of ORIC at the University of Sahiwal from June 2022 to January 2023 📊. Since February 2023, he has been the Focal Person for the Higher Education Commission at the University of Sahiwal 🎓.

Awards

Dr.Muhammad Ayub has earned numerous prestigious accolades throughout his career. In 2017, he was awarded the International Research Support Initiative Program (IRSIP) by the Higher Education Commission (HEC) of Pakistan to conduct research at The University of Queensland, Australia 🇦🇺. In 2019, he secured the Interim Placement Program for Fresh PhDs (IPFP-HEC) 🏅. The same year, he achieved first position 🥇 in a paper presentation at the 1st National Conference on Multidisciplinary Research (NCMR-2019), University of Okara. Additionally, he won a highly competitive research grant of 2.71 million PKR 💰 under the National Research Program for Universities (NRPU-HEC).

Training Workshop

Dr. Muhammad Ayub has actively participated in various workshops and training programs to enhance his research and scientific writing skills. On February 26, 2018, he attended a workshop on “Writing Scientific Research” 📄 at the Department of Chemistry, University of Agriculture, Faisalabad. He further honed his expertise by joining a “Bioassays for Exploration of Bioactivities” 🧪 training session on March 20, 2018, at the Department of Biochemistry. Additionally, on December 16, 2019, he attended a prestigious training session at Tel Aviv University 🎓 on “How to Write a Great Research Paper and Get it Accepted”, presented by Elsevier experts.

Research Focus

Dr. Muhammad Ayub’s research primarily focuses on essential oil extraction, natural product chemistry, and material science 🧪🌿. His studies involve optimizing short-path molecular distillation, superheated steam distillation, and other advanced extraction techniques for obtaining bioactive compounds from plants 🌱. He investigates the antioxidant, antimicrobial, and pharmacological properties of essential oils, comparing conventional and innovative extraction methods 🔬. Additionally, his work extends to polymer chemistry, particularly the use of biopolymers like carboxymethyl cellulose in polyurethane synthesis for thermal applications 🔥. His interdisciplinary approach bridges natural product chemistry, pharmacology, and material science to develop functional bioactive compounds.

Publication Top Notes

Short path molecular distillation of the essential oil from Pinus roxburghii oleoresin affords volatile fractions with powerful antioxidant and antimicrobial activities comparable with common synthetic agents and antimicrobials

Use of carboxymethyl cellulose in polyurethane synthesis for thermal applications

Comparative Pharmacological Potential of Cumin (Cuminum cyminum) Seed Essential Oils: Conventional vs. Superheated Steam Distillation

Comparative Study of Essential Oils Extracted From Foeniculum vulgare Miller Seeds Using Hydrodistillation, Steam Distillation, and Superheated Steam Distillation

Optimizing the extraction of essential oil yield from Pistacia lentiscus oleo-gum resin by superheated steam extraction using response surface methodology

Chuan Fan | Nanomedicine | Best Researcher Award

Published on 14/02/202514/02/2025 by Top Pharmaceutical

Chuan Fan | Nanomedicine | Best Researcher Award

Dr Chuan Fan,Linyi University,China

Dr. Chuan Fan 🎓🔬 is a lecturer at Linyi University’s School of Chemistry and Chemical Engineering, specializing in multifunctional hydrogel dressing systems and acoustic-driven biomarker analysis. He earned his degree from the University of Science and Technology Beijing under Prof. Xueji Zhang. With 30+ SCI- and Scopus-indexed publications and a ResearchGate citation index of 984, his research contributes to pharmacology and drug delivery. However, he is in the early stages of securing patents, grants, and industry collaborations. His work holds promise for advanced therapeutic applications, making him a strong contender for early-career research awards. 🏆📚

Publication Profile

Scopus

Academic and Professional Background

Dr. Chuan Fan 🎓 pursued his studies at the University of Science and Technology Beijing under the esteemed mentorship of Professor Xueji Zhang. Since August 2023, he has been serving as a lecturer at Linyi University’s School of Chemistry and Chemical Engineering 🏫. His research primarily focuses on multifunctional hydrogel dressing systems and acoustic-driven enrichment analysis of trace biomarkers 🧪. Through his dedication and innovation, Dr. Fan has made significant progress in his field, contributing to multiple high-quality publications in indexed journals 📚. His work continues to advance scientific knowledge and practical applications in chemical and biomedical research. 🚀

Research and Innovations

Dr. Chuan Fan has made notable contributions to his field, authoring over 30 SCI- and Scopus-indexed articles 📄, reflecting his dedication to research. His citation index on ResearchGate stands at 984 🔍, indicating a moderate academic impact. However, his research engagement appears to be in its early stages, with no completed projects and only two ongoing ones 🧪. Despite his publication record, he has yet to secure patents, editorial appointments, industry collaborations, consultancy projects, or book publications 📚. While his work is promising, further achievements in these areas could enhance his influence in the scientific community. 🌟

Contributions and Impact

Dr. Chuan Fan is dedicated to advancing pharmacology and drug delivery systems, with a focus on enhancing targeted therapies and improving patient outcomes 💊🔬. His research explores innovative methods to optimize drug efficacy and minimize side effects, contributing to the evolving landscape of precision medicine. While he asserts that his work has gained significant recognition, concrete evidence such as prestigious awards, keynote invitations, or high-impact citations remains unspecified 🏆📖. Despite this, his contributions reflect a commitment to revolutionizing drug delivery, potentially shaping future advancements in personalized treatment strategies for various medical conditions 🚀🧬.

Professional Engagements

Dr. Chuan Fan currently does not hold any professional memberships, editorial roles, or collaborative positions, which are key indicators of a researcher’s influence in the academic community 📚. Actively participating in international conferences 🌍, joining professional societies 🏛️, and engaging in research networks 🔬 would significantly enhance his professional standing. Such involvement fosters knowledge exchange, strengthens collaborations, and increases visibility within the scientific community. By contributing to peer-reviewed journals ✍️, networking with experts 🤝, and taking on leadership roles, Dr. Fan can expand his impact and establish himself as a recognized authority in his field of expertise.

Research Focus

Dr. Chuan Fan’s research focuses on biomedical materials 🧪, nanotechnology 🧫, and wound healing 🩹, particularly in developing visible light-activated Ti-MOF (titanium-metal-organic frameworks) hydrogel composites for chronic diabetic wound healing 🦶. His work integrates photocatalysis 🌞, drug delivery 💊, and biocompatible hydrogels to enhance tissue regeneration and antimicrobial effects. By loading metformin into these advanced biomaterials, Dr. Fan aims to promote faster and more effective healing of diabetic wounds, addressing a critical medical challenge. His research sits at the intersection of materials science 🏗️, biomedical engineering ⚙️, and regenerative medicine 🧬.

Publication Top Notes

Visible light-activated Ti-MOF loaded metformin-hydrogel composite dressing for accelerated chronic diabetic wound healing

Bo Meng | Pharmaceutical Biotechnology | Top Pharmaceutical Scientist Award

Published on 13/02/202513/02/2025 by Top Pharmaceutical

Bo Meng | Pharmaceutical Biotechnology | Top Pharmaceutical Scientist Award

Dr Bo Meng, WuXi Biologics, China

🔬 Dr. Bo Meng is an Associate Director at WuXi Biologics, Shanghai 🇨🇳 (2017–present), leading 30+ CMC projects for biologics like antibodies, enzymes, and vaccines. 💉 He manages a team of 20+ scientists, driving innovations from pre-IND to BLA filings. Previously, he was a Research Scientist at Omicron Biochemicals, USA 🇺🇸, focusing on glycan synthesis. 🧪 Dr. Meng earned his Ph.D. in Organic Chemistry from the University of Tennessee 🎓 and a B.Sc. in Applied Chemistry from Beijing Institute of Technology. 📖 His research is published in top journals, and he holds a Lean Six Sigma Green Belt. 🏆

Publication Profile

Orcid

Education

Dr. Bo Meng 🎓 earned a Ph.D. in Organic Chemistry 🧪 from the University of Tennessee, Knoxville 🇺🇸, completing his studies in August 2015. His academic journey began at Beijing Institute of Technology 🇨🇳, where he obtained a Bachelor’s degree in Applied Chemistry ⚗️ in June 2010. With a strong foundation in chemical sciences and research, Dr. Meng has developed expertise in organic synthesis and chemical applications. His educational background reflects a dedication to advancing scientific knowledge and contributing to innovative research in the field of chemistry 🔍🔬.

Working Experience

Dr. Bo Meng is the Associate Director at WuXi Biologics in Shanghai, China (2017–present) 🇨🇳🔬. With expertise in biologics development, he leads 30+ CMC projects, including antibodies, fusion proteins, ADCs, enzymes, vaccines, and mRNA 💉🧬. As Project Head, he oversees cell line development, process optimization, and regulatory filings from pre-IND to BLA 📑⚙️. He also manages a 20-person analytical team, ensuring robust assay development, product stability, and regulatory compliance. Previously, he worked at Omicron Biochemicals Inc. in the USA (2015–2017) 🇺🇸⚗️, contributing significantly to innovative biopharmaceutical advancements.

Research Scientist

Dr. Bo Meng specializes in the chemical and enzymatic synthesis, purification, and analysis of oligosaccharides 🧪, with a focus on high-mannose N-glycans, mannose phosphates, and 13C-labeled sugars 🧬. These complex carbohydrates play a crucial role as therapeutic targets in pathology and immunological studies 🩺🛡️. Through innovative research and advanced analytical techniques, Dr. Meng contributes to the development of new treatments and diagnostic tools for various diseases. Their work bridges the gap between biochemical research and medical applications, enhancing our understanding of immune responses and disease mechanisms for better healthcare solutions 🌱💡.

Research Focus

Dr. Bo Meng’s research spans biopharmaceuticals, carbohydrate chemistry, and materials science. 🧪🔬 His recent work investigates excipient impacts on polysorbate 80 degradation in biopharmaceutical formulations. 💉🧫 He has explored regioselective glycosylation to synthesize high-mannose oligosaccharides with mannose-6-phosphate residues. 🍬⚛️ Additionally, Dr. Meng has contributed to developing hyper-crosslinked cyclodextrin polymers for efficient CO₂ capture and catalytic applications. 🌿🛠️ His innovative work in carbohydrate-based materials showcases potential for green chemistry, biotechnology, and drug formulation. 🌏💊 Through interdisciplinary approaches, he advances solutions for environmental challenges and pharmaceutical stability. 📈🔍

Publication Top Notes

Investigation of excipients impact on polysorbate 80 degradation in biopharmaceutical formulation buffers

Synthesis of high-mannose oligosaccharides containing mannose-6-phosphate residues using regioselective glycosylation

Rapid assembly of branched mannose oligosaccharides through consecutive regioselective glycosylation: A convergent and efficient strategy

Hyper-crosslinked cyclodextrin porous polymer: an efficient CO<sub>2</sub> capturing material with tunable porosity

Hyper-crosslinked β-cyclodextrin porous polymer: an adsorption-facilitated molecular catalyst support for transformation of water-soluble aromatic molecules

Carbohydrate based hyper-crosslinked organic polymers with –OH functional groups for CO<sub>2</sub> separation

1,2-cis Alkyl glycosides: straightforward glycosylation from unprotected 1-thioglycosyl donors

ZnI2-Catalyzed Cyanation of Acyl Chlorides with TMS-CN: An Interesting Role of Iodine

Randa El-Mofty | Nanomedicine | Best Researcher Award

Published on 13/02/202513/02/2025 by Top Pharmaceutical

Randa El-Mofty | Nanomedicine | Best Researcher Award

Dr Randa El-Mofty ,Cairo university, Egypt

👩‍⚕️ Dr. Randa El-Mofty is an accomplished ophthalmologist from Cairo University, Egypt 🇪🇬, with an M.D. in Ophthalmology (2013) and extensive training in cornea and oculoplasty. 👁️ She specializes in clinical electrophysiology of vision, pediatric ophthalmology, and strabismus. As an Associate Professor, she mentors students and residents while contributing to global research. 🧠🔬 Her work includes studies on diabetic retinopathy, nystagmus, and retinal dystrophies. Dr. El-Mofty is a member of prominent societies like ISCEV and EgSCRS. 🌐 Her passion for eye health is evident in her publications, presentations, and international collaborations. 🏥✨

Publication Profile

Google Scholar

Education

Dr. Randa El-Mofty, M.D. 🎓, is an accomplished ophthalmologist with a medical degree from Cairo University, Egypt. She earned her doctorate in 2013 with a thesis on the role of amniotic membrane transplant in reducing postoperative adhesions after strabismus reoperations 👁️🩺. She also holds a Master’s degree (2009) with a thesis on a simple method for spherical implant implantation. Dr. El-Mofty graduated with Excellence and Honors for her M.B.B.CH. degree 🏆 and achieved a remarkable 99.5% in her Thanaweya Amma. Fluent in French 🇫🇷, she passed the Examen Alliance Française with distinction. Her educational journey began at Collège de la Mère de Dieu 📖.

Clinical Expertise

Dr. Randa El-Mofty, M.D., is a dedicated ophthalmologist with extensive clinical experience, gained through her fellowship in oculoplasty and cornea specialties. 🌟👁️ She currently serves as an Associate Professor at Cairo University, where she excels in providing top-quality care in adult and pediatric ophthalmology. 🧒👓 Her passion for eye health and commitment to academic excellence have made her a respected figure in the field. With a patient-centered approach and a drive for continuous learning, Dr. El-Mofty contributes significantly to advancing ophthalmic knowledge and delivering exceptional care to patients of all ages. 📖

Teaching & Mentoring

Dr. Randa El-Mofty, M.D., is a dedicated educator and mentor with a strong focus on clinical electrophysiology of vision 👁️⚡. Passionate about advancing eye care, she has actively contributed to both undergraduate and postgraduate education 🎓📚. Her guidance has led to significant research projects exploring ocular disorders and pioneering treatment innovations 🔍💡. Through her work, Dr. El-Mofty continues to inspire future generations of vision specialists while promoting innovative diagnostic and therapeutic techniques. Her commitment to education and research plays a crucial role in enhancing the understanding and treatment of various eye conditions 👩‍⚕️🔬.

Presentations

Dr. Randa El-Mofty, M.D., is a distinguished expert in clinical electrophysiology of vision, actively contributing to national conferences and courses in Egypt 🇪🇬👁️. She has served as an instructor, moderator, and presenter at major events like the Kasr Al-Aini Ophthalmology Department Annual Meeting (2025) and Eye World Hospital CME courses (2024). Her insightful presentations cover topics like retinal dystrophy biomarkers, rod-cone dystrophy, and VEP applications. She engages in pediatric ophthalmology discussions at the Egyptian Ophthalmology Society and ESIO. Dr. El-Mofty’s dedication to advancing vision science underscores her impactful role in ophthalmology education and clinical practice 🎓🔍.

Research Focus

Dr. RMAM El-Mofty’s research primarily focuses on ophthalmology 👁️, particularly strabismus surgery, amniotic membrane transplantation, and ocular tissue healing 🧵. Her work explores the use of cryopreserved amniotic membranes in reducing adhesions and fibrosis during extraocular muscle surgeries 🐇🔬. She investigates different membrane orientations, long-term outcomes, and innovations in strabismus reoperations 🏥. Additionally, she studies ocular toxicology, including the effects of gold nanoparticles on eye health ⚛️. Recent work also covers orbital infarction syndrome and surgical outcomes in exotropia correction 🩺. Her research aims to improve surgical techniques and enhance postoperative recovery in ophthalmic procedures 👓🔍.

Publication Top Notes

Effect of cryopreserved amniotic membrane on the development of adhesions and fibrosis after extraocular muscle surgery in rabbits

Amniotic membrane transplantation in strabismus surgery

A controlled study of the role of cryopreserved amniotic membrane transplant during strabismus reoperations

A comparative study of different amniotic membrane orientations during extraocular muscle surgery in rabbits

Long-term follow-up of cryopreserved amniotic membrane transplant during strabismus reoperations: up 85 months’ follow-up

Gold Nanoparticles and Induction of Structural Alteration and Enhanced Oxidative Stress in Rat Lens

Unilateral versus bilateral lateral rectus recession for correction of small to moderate angle exotropia

Presumed Orbital Infarction Syndrome after Functional Endoscopic Sinus Surgery (FESS)

Ala Hssain | Drug Discovery and Development | Best Researcher Award

Published on 12/02/202512/02/2025 by Top Pharmaceutical

Ala Hssain | Drug Discovery and Development | Best Researcher Award

Ms Ala Hssain,University of Halabja,Iraq

Dr. Ala Hamd Hssain 🇮🇶 is a dedicated physicist specializing in material science and quantum mechanics. She earned her PhD in Material Science (2023) from Firat University, Turkey, and her Master’s in Quantum Mechanics (2014) from Eastern Mediterranean University, Cyprus. Currently, she is a faculty member at University of Halabja, Iraq, teaching quantum mechanics and advanced calculus. Her research focuses on DFT simulations, molecular modeling, and hydroxyapatite materials, with numerous publications in high-impact journals 📚. Proficient in Gaussian, Vesta, and Multiwfn, she actively contributes to scientific advancements in computational and experimental physics. ✨

Publication Profile

Scopus

Education

Ms. Ala Hssain 🎓 earned her Ph.D. in Material Science (2019-2023) from Firat University, Faculty of Science, Physics Department, in Elazig, Turkey 🇹🇷. She previously completed her Master’s degree in Quantum Mechanics (2012-2014) at Eastern Mediterranean University, Cyprus 🇨🇾, under the supervision of Prof. Dr. Habib Mazharimousavi. Her academic journey began with a Bachelor’s degree in Physics from Salahaddin University 🎓. With a strong foundation in physics and material science, she has dedicated her research to advancing knowledge in these fields, contributing to cutting-edge developments in quantum mechanics and material engineering. ⚛️🔬

Academic Experience

Ms. Ala Hssain 🎓 has a rich background in teaching and laboratory assistance. She served as an assistant physicist at the University of Sulaimani 🔬, working in optics, electricity, and measurement labs (2009-2010), solid-state and atomic labs (2010-2011), and atomic labs (2011-2012). Later, she became a lecturer at the University of Halabja 📚, teaching Calculus, scientific debate, atomic labs, metrology, and electricity & magnetism between 2014 and 2018. Currently, she continues her academic journey as a Quantum Mechanics professor ⚛️ for third-year students at the University of Halabja, contributing to the next generation of physicists. 🚀

Research Experience

Ms. Ala Hssain 🎓 is proficient in advanced computational tools for molecular simulations and density functional theory (DFT) 🔬. She has expertise in Gaussian software for molecular modeling, enabling precise quantum mechanical calculations ⚛️. Additionally, she is skilled in VESTA for 3D visualization of crystal structures 🏗️, VMD for molecular dynamics simulations 🧬, Multiwfn for wavefunction analysis 🌊, and Siesta for efficient DFT calculations on complex materials 🏢. Her expertise in these tools enhances her research in material science, quantum mechanics, and computational physics, contributing to innovative advancements in the field. 🚀

Academic Activities

Ms. Ala Hssain 🎓 has an extensive research portfolio, focusing on material science, quantum mechanics, and computational chemistry 🔬. Her publications explore hydroxyapatite co-doping, spinel synthesis, and optoelectronic compounds. Notable works include DFT modeling of Secnidazole 🧪, structural and spectroscopic studies on serotonin ⚛️, and Mg-doped Zn-based hydroxyapatites 🏗️. She has also contributed to theoretical and experimental research on L-tryptophan dimers 🧬. Published in prestigious journals like Chemical Physics Letters and Journal of Molecular Structure, her studies drive advancements in materials chemistry, nanotechnology, and molecular simulations. 🚀📖

Research Focus

Ms. Ala Hssain’s research focuses on Computational and Experimental Chemistry 🧪, particularly in the structural and spectroscopic analysis of biomolecules. Her work on the L-tryptophan dimer state involves a combination of Density Functional Theory (DFT)🖥️ and Molecular Dynamics (MD) simulations to understand molecular interactions and stability. This interdisciplinary research bridges theoretical modeling and experimental validation, contributing to fields like biophysics 🧬, pharmaceutical sciences 💊, and material chemistry 🔬. Her expertise lies in using computational tools to predict molecular behavior, aiding in drug design and biomolecular engineering. Her findings enhance the understanding of amino acid interactions in biological systems.

Publication Top Notes

Structural and spectroscopic study of L-tryptophan dimer state using DFT and MD: Computational and experimental analysis

Yongxiang Zhao | Gene Therapy | Best Researcher Award

Published on 12/02/202512/02/2025 by Top Pharmaceutical

Yongxiang Zhao | Gene Therapy | Best Researcher Award

Prof. Dr Yongxiang Zhao,Guangxi Medical University,China

Prof. Dr. Yongxiang Zhao, Director of the State Key Laboratory of Targeted Oncology, is a renowned expert in tumor diagnosis and treatment. A recipient of the Ho Leung Ho Lee Award 🏆 and a leader in the Yangtze River Scholars Award Program, he pioneered the world’s first gene-edited liver cancer monkey model 🧬 and developed the first intravenous recombinant NDV oncolytic virus 🦠, showing a 90% disease control rate in Phase III trials. With over 160 SCI papers 📄 and 46 invention patents, he has led 30+ major drug development projects, shaping the future of cancer therapy. 🚀

Publication Profile

Scopus

Outstanding Leadership and Recognition

Prof. Dr. Yongxiang Zhao 🎓 is a globally renowned researcher and a visionary leader in the scientific community. As the Director of the State Key Laboratory of Targeted Oncology 🏥, he has spearheaded groundbreaking advancements in cancer research. His outstanding achievements have earned him prestigious honors, including the Ho Leung Ho Lee Award 🏆. Additionally, he leads national innovation programs such as the Yangtze River Scholars Award Program Innovation Team 🌊 and the Ten Thousand Talents Program 🌟. These recognitions underscore his influential role in shaping the future of scientific discovery and fostering innovation on a national and international scale.

Contributions to Oncology

Prof. Dr. Yongxiang Zhao 🎓 has made groundbreaking contributions to oncology, particularly in targeted tumor diagnosis and treatment. He pioneered the development of the world’s first gene-edited liver cancer monkey model 🧬🐒, a revolutionary advancement that has transformed cancer research. This innovative model provides an exceptionally accurate system for studying liver cancer, paving the way for more effective treatment strategies 💊. His work has significantly enhanced our understanding of tumor progression and therapeutic interventions, solidifying his reputation as a leader in oncology 🔬. Through his pioneering research, Dr. Zhao continues to drive innovation and shape the future of cancer treatment.

Breakthrough Innovations in Cancer Treatment

Prof. Dr. Yongxiang Zhao 🎓 has achieved a groundbreaking milestone in cancer treatment with the development of the world’s first intravenous recombinant Newcastle Disease Virus (NDV) oncolytic virus 🦠💉. This revolutionary therapy targets 13 advanced cancers, including liver cancer, offering a promising new approach to oncology. Multi-center clinical trials demonstrated an impressive Disease Control Rate (DCR) of 90% 📊, leading to Phase III clinical trials. This breakthrough has the potential to transform cancer therapy, providing new hope to patients worldwide 🌍. Dr. Zhao’s innovative work continues to push the boundaries of medical science, redefining the future of cancer treatment.

Extensive Research and Intellectual Property

Prof. Dr. Yongxiang Zhao 🎓 is a prolific researcher whose contributions have profoundly impacted oncology and drug development. With over 160 SCI publications 📄, including influential papers in top-tier journals like Cell 🧬, his work has advanced scientific understanding in the field. His innovative mindset is reflected in 46 invention patents 🏅, highlighting his role as a pioneer in medical research. Leading over 30 major national drug development projects 💊, Dr. Zhao has played a crucial role in translating groundbreaking discoveries into real-world medical applications, shaping the future of cancer treatment and improving patient outcomes globally 🌍.

Research Focus

Dr. Yongxiang Zhao’s research primarily focuses on nanomedicine, drug delivery systems, and cancer therapeutics. His work spans polymeric nanoparticles 🧪, exosomal RNA therapies 🧬, and aptamer-based antiviral strategies 🦠, particularly targeting multidrug-resistant bacterial infections and cancer treatment 🎗️. He also explores biocompatible microspheres for tissue repair 🏥 and oncology-focused biomaterials. His research integrates biomedical engineering 🏗️, molecular biology 🧫, and clinical applications. Dr. Zhao’s contributions extend to tumor microenvironment studies, cancer-associated fibroblasts 💊, and immunotherapeutic bacteria 🦠 for precision medicine, making significant strides in advanced therapeutics and biomaterials development.

Publication Top Notes

Moxifloxacin-Loaded Polymeric Nanoparticles for Overcoming Multidrug Resistance in Chronic Pulmonary Infections Caused by Pseudomonas aeruginosa

The function of albumin and its application in tumor therapy

Aptamers targeting SARS-CoV-2 nucleocapsid protein exhibit potential anti pan-coronavirus activity

Heterogeneity and interplay: the multifaceted role of cancer-associated fibroblasts in the tumor and therapeutic strategies

Exosomal lncRNA ROR1-AS1 from cancer-associated fibroblasts inhibits ferroptosis of lung cancer cells through the IGF2BP1/SLC7A11 signal axis

Correction to: Engineering a precise adenine base editor with minimal bystander editing (Nature Chemical Biology, (2023), 19, 1, (101-110), 10.1038/s41589-022-01163-8)

Polymer Microspheres and Their Application in Cancer Diagnosis and Treatment

Microalgae-loaded biocompatible alginate microspheres for tissue repair

Landscape of global urban environmental resistome and its association with local socioeconomic and medical status

Oncolytic mineralized bacteria as potent locally administered immunotherapeutics

Berat Cinar Acar | Biopharmaceutics | Best Researcher Award

Published on 12/02/202512/02/2025 by Top Pharmaceutical

Berat Cinar Acar | Biopharmaceutics | Best Researcher Award

Dr Berat Cinar Acar,Department of Biology,Turkey

🔬 Dr. Berat Çınar Acar is a dedicated biologist specializing in microbiology and environmental biotechnology. He earned his Ph.D. in Biology from Gazi University (2018), focusing on bioremediation of chromium in industrial wastewater. His M.Sc. (2012) explored β-glucosidase enzyme activity in Lactobacillus and Bifidobacterium species. Currently a lecturer at Gazi University, he has led and contributed to multiple scientific research projects on microbial biotechnology and environmental detoxification. His research advances sustainable solutions for pollution control and microbial enzyme applications. 🌍🧪

Publication Profile

google scholar

Education Information

Dr. Berat Cinar Acar 🎓 earned his Ph.D. in Biology from Gazi University’s Institute of Science on May 30, 2018. His doctoral research focused on beta-glucosidase enzyme activity and isoflavone hydrolysis in Lactobacillus and Bifidobacterium under the supervision of Assoc. Prof. Zehra Nur Yüksekdağ. He completed his M.Sc. in Biology at Gazi University in 2012 and obtained his B.Sc. in Biology from Niğde University in 2008. With a strong academic background, he currently serves as a Lecturer in the Department of Biology at Gazi University, contributing to research and education in the field of microbiology 🔬.

Academic Duties

Dr. Berat Çınar Acar is a dedicated faculty member 🏫 at Gazi University, Faculty of Science, Department of Biology, specializing in the field of biology 🔬. As a lecturer, he plays a vital role in academic research and education, guiding students in various biological disciplines 📚. His expertise spans microbiology, biotechnology, and environmental sciences, contributing to innovative studies on probiotics, enzyme activities, and bioremediation 🌱🦠. Dr. Acar’s commitment to scientific advancement and education continues to inspire future researchers and professionals, fostering a deeper understanding of biological sciences for sustainable solutions to global challenges. 🌍

Awards

Dr. Berat Cinar Acar 🏆 was honored with the Gazi University Rectorate Incentive Award in 2024 for his outstanding contributions to scientific research and academic excellence. This prestigious recognition highlights his dedication to advancing biological sciences and his impactful work in microbiology 🔬. As a distinguished academic at Gazi University, Dr. Acar continues to inspire students and researchers through his innovative studies and commitment to education 📚. His achievements reflect his passion for scientific discovery and his ongoing efforts to push the boundaries of knowledge in his field.

Certificate

Dr. Berat Cinar Acar 📜 has earned multiple prestigious certifications, showcasing his expertise in advanced scientific techniques. In 2023, he received Mikrobiyota Education and Real-Time PCR Training Certificates 🧬 from Krosgen. His international certification in ICP-OES OPTIMA (2017) reflects his proficiency in analytical instrumentation 🔬. Additionally, he completed the Oba Chemometrics Training in Antalya (2015) and gained expertise in GC-MS instrumentation and ChemStation software from Agilent Technologies in Ankara (2012). These certifications highlight his dedication to continuous learning and innovation in microbiology, biotechnology, and analytical sciences 🏅

Works

Dr. Berat Çınar Acar is an esteemed researcher with significant contributions to microbiology, nanotechnology, and environmental science 🧪🌍. His work spans antimicrobial activity, bioremediation, and probiotic research, with publications in top-tier journals like Microscopy Research and Technique and Water, Air, and Soil Pollution 📖🔬. He has explored green synthesis of silver nanoparticles, cold plasma applications for food safety, and bioreduction of heavy metals. His international conference presentations showcase innovations in probiotic enzyme activity and biosurfactants 🦠🛡️. Dr. Acar’s research advances biotechnology and public health, addressing critical environmental and food safety challenges. 🚀

Duties Performed in Projects

Dr. Berat Çınar Acar has contributed significantly to various scientific research projects, focusing on microbiology, biotechnology, and environmental sciences 🧪🌱. His work includes chromium detoxification via bioremediation, probiotic bacterial studies, and beta-galactosidase enzyme activity analysis. He has led projects on cold atmospheric plasma applications for pathogen inactivation, biosorption techniques, and the antibacterial properties of hydrogels infused with silver nanoparticles. Additionally, Dr. Acar investigates extracellular polysaccharide production in probiotic strains and the bactericidal effects of ozone and plasma treatments against clinical pathogens 🦠🔬. His research continues to advance sustainable and innovative scientific solutions for health and the environment. 🌍✨

Research Focus

Dr. Berat Çınar Acar specializes in microbiology 🦠, probiotics 🥛, enzyme activity 🧪, and environmental biotechnology 🌱. His research focuses on probiotic bacteria, particularly Lactobacillus and Bifidobacterium species, exploring their β-glucosidase and β-galactosidase enzyme activities. He also investigates bioremediation for heavy metal removal and the biological cementation of soils. Additionally, his work extends to antimicrobial activities 🔬, folate production, and nanotechnology-based green synthesis 🌿⚗️. His studies contribute to food biotechnology, environmental sustainability, and innovative biomedical applications, making his research crucial for human health, nutrition, and ecological balance.

Publication Top Notes

Probiotic properties of lactobacilli species isolated from children’s feces

β-Glucosidase activity and bioconversion of isoflavone glycosides to aglycones by potential probiotic bacteria

Cementation in a matrix of loose sandy soil using biological treatment method

Beta-Glycosidase Activities of Lactobacillus spp. and Bifidobacterium spp. and The Effect of Different Physiological Conditions on Enzyme Activity

Kimyasal yöntemlerle atık sulardan ağır metal giderimi

Investigation of Chromium (III) Adsorption on Acid-Treated Bentonite Evaluation of Kinetic/Thermodynamic Data

Bioreduction of Cr(VI) by Raoultella ornithinolytica BCA13 Obtained from Tannery Effluent

Lactobacillus cinsi bakteriler tarafından üretilen biyosürfektanların anti-biyofilm ve anti-mikrobiyal aktivitelerinin belirlenmesi

Analyzing antimicrobial activity of ZnO/FTO, Sn–Cu‐doped ZnO/FTO thin films: Production and characterizations

Lactobacillus ve bifidobacterium cinsi bakterilerin beta-glukozidaz enzim aktivitesi ve izoflavon hidrolizi

Francesco Ceppa | Precision Medicine | Excellence in Research

Published on 08/02/202508/02/2025 by Top Pharmaceutical

Francesco Ceppa | Precision Medicine | Excellence in Research

Dr Francesco Ceppa,Università cattolica del sacro cuore,Italy

Dr. Francesco Ceppa 👨‍⚕️Born on May 15, 1994, in Pescara, Italy 🇮🇹, Dr. Francesco Ceppa is a dedicated medical professional specializing in Emergency Medicine at the prestigious A. Gemelli Hospital, Università Cattolica del Sacro Cuore 🏥. A graduate in Medicine and Surgery 🎓 (2020), he has excelled with advanced certifications like Advanced Life Support (ALS) 🩺. Dr. Ceppa gained invaluable experience as a COVID-19 vaccinator and through clinical roles in emergency medicine and abdominal surgery. Fluent in Italian 🇮🇹 and proficient in English 🌍, he combines excellent interpersonal 🤝, organizational 📋, and technical skills 💻 to advance patient care.

Publication Profile

orcid

Academic Background

Dr. Francesco Ceppa is a dedicated medical professional who graduated from the Università Cattolica del Sacro Cuore with a degree in Medicine and Surgery, earning an impressive score of 101/110 🎓. His strong academic foundation is complemented by an outstanding high school diploma 📚 and proficiency in English at the C1 level 🌍. In line with his commitment to excellence in healthcare, Dr. Ceppa obtained an Advanced Life Support (ALS) certification in 2022 🩺, equipping him to handle critical medical situations with expertise. His achievements highlight his passion for advancing his skills and making a meaningful impact in the field of medicine. 💡✨

Professional Experience

Dr. Ceppa has showcased exceptional expertise through various impactful roles. 💉 During the COVID-19 pandemic, he actively contributed to public health by participating in antigen testing and vaccination campaigns. 🩺 His journey in Emergency Medicine began with a residency at the renowned Agostino Gemelli University Hospital, highlighting his commitment to critical care and acute medical settings. 🚨 Additionally, Dr. Ceppa has been involved in clinical collaborations with key departments, including surgery and translational medicine, fostering interdisciplinary connections that may pave the way for groundbreaking research. 🔬 His dedication exemplifies a blend of hands-on care and forward-thinking innovation. 🌟

Research Contributions

Dr. Francesco Ceppa is a dedicated medical professional with exceptional expertise in emergency medicine, holding an Advanced Life Support (ALS) certification 🩺. Renowned for his technical proficiency, he is rated “excellent” in utilizing medical equipment and computer systems for efficient healthcare delivery 💻. His outstanding teamwork and organizational skills 🤝 ensure seamless collaboration in research and clinical settings. However, his CV lacks explicit mention of peer-reviewed publications, conference presentations, research grants, or independent projects, as well as specific contributions to advancing medical science or methodologies. Strengthening these areas could further highlight his impact and expertise in the medical field. 📚✨

Research Focus

Dr. Francesco Ceppa’s research focuses on the prognostic value of procalcitonin in febrile conditions among people living with HIV (PLWH) admitted to the emergency department. His work bridges the fields of infectious diseases 🦠, emergency medicine 🚑, and clinical biomarkers 🧬, aiming to enhance diagnostic precision and improve patient outcomes. By investigating the role of procalcitonin as a biomarker in febrile PLWH, Dr. Ceppa contributes to better management of critical illnesses and infectious complications. His research impacts public health 🌍 and provides insights into personalized approaches to care for immunocompromised individuals.

Publication Top Notes

Prognostic Value of Procalcitonin in Febrile People Living with Human Immunodeficiency Virus (PLWH) Admitted to the Emergency Department